Skip to main content
. Author manuscript; available in PMC: 2018 Apr 21.
Published in final edited form as: Vaccine. 2018 Feb 21;36(9):1183–1189. doi: 10.1016/j.vaccine.2018.01.033

Table 3.

Hepatitis B vaccination coverage by demographic and access to care characteristics among adults with and without chronic liver disease (CLD), National Health Interview Survey, United States, 2014–2015

With CLD Without CLD
Characteristic Unweighted
N
Weighted %
vaccinated
(3+ doses)
Adjusted
prevalence
difference*
(95% CI))
Unweighted
N
Weighted %
vaccinated
(3+ doses)
Adjusted
prevalence
difference*
(95% CI))
Total 830 29.1 (25.3, 33.0) 62,015 24.7 (24.2, 25.3)
Age
  18–49 227 37.1 (29.2, 45.0) Referent 30,418 32.2 (31.4, 33.6) Referent
  50–64 366 33.4 (27.8, 39.0) −4.5 (−14.7, 5.6) 16,243 19.8 (18.9, 20.6)§ −12.4 (−13.6, −11.2)
  ≥65 237 12.1 (7.4, 16.8) −24.9 (−35.7, −14.1) 15,354 10.7 (9.9, 11.4) −20.8 (−22.3, −19.4)
Gender
  Male 394 24.9 (19.6, 30.2) Referent 27,591 20.8 (20.0, 21.6) Referent
  Female 436 33.1 (27.7, 38.5) 8.1 (−0.5, 16.7) 34,424 28.3 (27.6, 29.1) 7.0 (5.9, 8.0)
Education
  < High school 186 18.2 (11.6, 24.8) Referent 8,869 12.7 (11.6, 13.7) Referent
  High school graduate 227 26.8 (19.7, 33.9) 7.7 (−3.5, 18.8) 15,844 17.4 (16.4, 18.3)§ 3.5 (1.8, 5.1)
  Some college 240 36.1 (28.8, 43.4) 14.4 (2.5, 26.3) 19,156 29.3 (28.3, 30.3) 11.7 (10.0, 13.5)
  College degree or higher 175 32.7 (24.6, 40.8) 16.9 (2.6, 31.2) 17,899 31.4 (30.5, 32.4) 12.0 (10.2, 13.9)
EmploymentStatus
  Employed 290 31.2 (24.4, 38.0) Referent 36,057 28.5 (27.8, 29.2) Referent
  Unemployed 30 45.9 (23.9, 67.9) 15.4 (−6.1, 36.9) 2,484 25.9 (23.2, 28.5) −0.5 (−3.1, 2.1)
  Not in work force 510 26.5 (21.6, 31.3) 2.7 (−8.2, 13.5) 23,452 17.9 (17.1, 18.7)§ −2.8 (−3.9, −1.6)
Poverty
   Poverty or above 579 29.0 (24.3, 33.7) 2.9 (−7.8, 13.6) 49,373 25.4 (24.8, 25.9) −0.2 (−1.8, −1.4)
  Below Poverty 220 31.7 (22.9, 40.6) Referent 9,645 22.9 (21.4, 24.5) Referent
Insurance
  Private 350 28.7 (22.9, 34.5) Referent 37,767 27.4 (26.7, 28.1) Referent
  Public 398 28.0 (22.6, 33.4) 0 (−9.9,10.0) 16,601 19.9 (18.9, 20.9)§ 1.4 (−0.1, 2.8)
  None 81 36.9 (27.1, 46.7) 0.7 (−12.6, 14.0) 7,419 20.0 (18.6, 21.3)§ −1.5 (−3.2, −0.2)
Race/Ethnicity
  Non-Hispanic white 535 28.6 (23.6, 33.7) Referent 38,862 25.6 (24.8, 26.3) Referent
  Non-Hispanic black 81 23.5 (13.0, 34.1) −2.2 (−17.0, 12.5) 8,284 23.9 (22.6, 25.2) −1.6 (−3.1, 0)
  Non-Hispanic 146 29.4 (19.9, 39.0) 6.0 (−7.5, 19.4) 10,019 19.0 (17.8, 20.2) −6.2 (−7.6, −4.7)
  other 68 37.4 (23.0, 51.9) 8.0 (−6.5, 22.4) 4,850 30.5 (28.7, 32.2) 0.2 (−1.4, 1.9)
Region
  Northeast 139 22.3 (11.6, 33.1) Referent 10,016 23.0 (21.5, 24.5) Referent
  Midwest 152 39.6 (31.3, 47.8) 13.0 (−2.2, 28.2) 13,365 27.3 (26.0, 28.6)§ 3.6 (1.7, 5.4)
  South 265 25.7 (20.2, 31.3) 2.4 (−11.1, 15.8) 21,854 22.9 (22.1, 23.7) 0.7 (−1.0, 2.4)
  West 274 31.2 (23.1, 39.3) 0.7 (−14.0, 15.4) 16,780 26.5 (25.4, 27.6) 3.0 (1.1, 4.8)
Marital status
  Married 317 25.7 (20.1, 31.3) Referent 27,403 23.6 (22.9, 24.3) Referent
  Widowed 101 20.2 (8.4, 32.1) 3.0 (−11.6, 17.5) 6,040 9.6 (8.6, 10.6) −5.4 (−7.3, −3.4)
  Divorced/Separated 217 39.4 (31.9, 46.9) 10.1 (−1.3, 21.5) 10,593 21.6 (20.5, 22.7)§ 0.6 (−0.7, 2.0)
  Never Married 191 32.3 (23.1, 41.3) 3.5 (−7.4, 14.5) 17,855 31.2 (30.0, 32.4) 5.6 (4.3, 6.9)
Influenza vaccination in past 12 months
  Yes 457 30.5 (25.8, 35.2) 8.0 (0.1, 15.8) 27,491 27.9 (27.1, 28.8) 8.7 (7.5, 9.8)
  No 373 27.4 (21.3, 33.4) Referent 34,524 22.3 (21.6, 23.1) Referent
Has primary doctor
  Yes 766 28.4 (24.3, 32.4) −6.6 (−23.6, 10.5) 53,713 24.9 (24.3, 25.5) −0.7 (−2.3, 0.8)
  No 64 37.4 (23.9, 50.8) Referent 8,286 23.4 (22.1, 24.7) Referent
Number of office visits, past 12 months
  0 61 25.5 (10.8, 40.2) Referent 10,907 19.7 (18.6, 20.8) Referent
  1–3 247 26.8 (20.0, 33.7) −0.5 (−17.0, 16.1) 27,586 25.8 (25.0, 26.6) 3.9 (2.5, 5.3)
  4–9 236 26.0 (19.5, 32.6) 0 (−17.4, 17.3) 14,981 25.4 (24.2, 26.5) 5.6 (3.9, 7.3)
  ≥10 281 35.3 (28.8, 41.8) 10.3 (−8.3, 28.8) 8,386 26.8 (25.4, 28.3)§ 6.9 (5.0, 8.7)
Travel
  Yes 215 30.9 (23.1, 38.7) 0.9 (−8.8, 10.5) 20,116 31.2 (30.3, 32.1) 6.2 (5.1, 7.2)
  No 615 28.4 (24.4, 32.4) Referent 41,857 21.3 (20.7, 22.0)§ Referent
Diabetes
  Yes 203 27.1 (19.9, 34.4) 1.2 (−8.5, 10.9) 6,525 17.4 (16.1, 18.6)§ −0.5, (−2.2, 1.3)
  No 627 29.7 (25.3, 34.1) Referent 55,469 25.5 (24.9, 26.1) Referent
*

Adjusted for all other variables in Table 3.

97 respondents with CLD and 6,053 respondents without CLD were excluded from the analysis due to missing data for HepB vaccination status.

p < 0.05 compared with referent category.

§

p < 0.05 by t-test comparing coverage among those with CLD and without CLD.

Persons identified as Hispanic could be of any race. “Other” includes American Indian/Alaska Native, Asian, and multiracial persons.

Travel to regions with intermediate or high prevalence of hepatitis B virus infection, defined as reported travel outside of the USA since 1995 to location other than Europe, Japan, Australia, New Zealand, or Canada.